11.99

0.42% -0.05

Delcath Systems Inc (DCTH)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$12.04

Aprire:

$12.17

Volume 24 ore:

29,078

Relative Volume:

0.08

Capitalizzazione di mercato:

$397.55M

Reddito:

$2.07M

Utile/perdita netta:

$-47.68M

Rapporto P/E:

-3.6333

EPS:

-3.3

Flusso di cassa netto:

$-31.31M

1 W Prestazione:

+0.17%

1M Prestazione:

-5.14%

6M Prestazione:

+51.58%

1 anno Prestazione:

+192.08%

Intervallo 1D:

$11.93

$12.17

Intervallo di 1 settimana:

$11.19

$12.17

Portata 52W:

$3.70

$13.30

Delcath Systems Inc Stock (DCTH) Company Profile

Nome

Delcath Systems Inc

Settore

Healthcare (1188)

Industria

Medical Devices (148)

Telefono

(518) 743-8892

Indirizzo

566 QUEENSBURY AVENUE, QUEENSBURY, NY

Dipendente

Cinguettio

@delcathsystems

Prossima data di guadagno

2024-11-08

Ultimi documenti SEC

DCTH's Discussions on Twitter

Confronta DCTH con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
DCTH Delcath Systems Inc	11.99	397.55M	2.07M	-47.68M	-31.31M	-2.82
ABT Abbott Laboratories	113.54	196.18B	41.22B	5.77B	6.49B	3.29
SYK Stryker Corp	359.76	137.26B	21.97B	3.59B	3.21B	9.33
BSX Boston Scientific Corp	89.73	131.64B	15.91B	1.79B	1.89B	1.21
MDT Medtronic Plc	80.30	102.43B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	73.19	43.66B	6.60B	4.16B	490.10M	6.93

Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-06-28	Iniziato	Craig Hallum	Buy
2024-05-14	Iniziato	Stephens	Overweight
2022-07-26	Ripresa	Canaccord Genuity	Buy
2021-12-10	Iniziato	H.C. Wainwright	Buy
2021-03-09	Iniziato	Canaccord Genuity	Buy
2021-01-05	Iniziato	BTIG Research	Buy
2020-06-01	Iniziato	Laidlaw	Buy

Mostra tutto

Delcath Systems Inc Borsa (DCTH) Ultime notizie

Jan 01, 2025

Delcath Systems, Inc. (NASDAQ:DCTH) Short Interest Update - MarketBeat

Jan 01, 2025

Wall Street Analysts Believe Delcath Systems (DCTH) Could Rally 96.84%: Here's is How to Trade - MSN

Jan 01, 2025

Delcath Systems raises additional USD 16.3M in funding - Medical Buyer

Jan 01, 2025

Dec 31, 2024

Delcath Systems announces additional $16.3 million in funding from warrant exercises - MSN

Dec 31, 2024

Delcath Systems (NASDAQ: DCTH) Announces Recent Funding and Warrant AmendmentsQueensbury, New York, December 30, 2024 – Delcath Systems, Inc. (NASDAQ: DCTH) recently disclosed important financial developments through an 8-K filing with th - Defense World

Dec 31, 2024

Dec 30, 2024

Delcath secures $16.3 million from warrant exercises By Investing.com - Investing.com Nigeria

Dec 30, 2024

Delcath Systems Secures $16.3 Million in Funding Through Warrant Exercise to Propel Growth in Oncology Treatments - Tandav Media

Dec 30, 2024

Delcath secures $16.3 million from warrant exercises - Investing.com India

Dec 30, 2024

Delcath Systems Secures $16.3M from Warrant Exercise - TipRanks

Dec 30, 2024

Delcath Systems Raises $16.3M Through Warrant Exercise to Advance HEPZATO Melanoma Treatment - StockTitan

Dec 30, 2024

3 US Growth Companies To Watch With Up To 32% Insider Ownership - Simply Wall St

Dec 30, 2024

Dec 29, 2024

(DCTH) Technical Data - Stock Traders Daily

Dec 29, 2024

Analysts Expect Breakeven For Delcath Systems, Inc. (NASDAQ:DCTH) Before Long - Yahoo Finance

Dec 29, 2024

Dec 19, 2024

Does Delcath Systems (NASDAQ:DCTH) Have A Healthy Balance Sheet? - Simply Wall St

Dec 19, 2024

Where are the Opportunities in (DCTH) - Stock Traders Daily

Dec 19, 2024

Dec 16, 2024

Delcath Systems stock soars to 52-week high of $12.99 - Investing.com

Dec 16, 2024

Dec 15, 2024

Positive Preliminary Results from Delcath Systems’ FOCUS Trial Presented at the 2021 ASCO Annual Meeting - Marketscreener.com

Dec 15, 2024

Dec 13, 2024

Clear Street initiates Buy on Delcath Systems stock, highlights profitability potential - Investing.com

Dec 13, 2024

Dec 10, 2024

Thinking about buying stock in Nikola, Delcath Systems, Taysha G - GuruFocus.com

Dec 10, 2024

Dec 09, 2024

Uveal melanoma Treatment Market: Segmentation Trends, - openPR

Dec 09, 2024

Dec 08, 2024

When (DCTH) Moves Investors should Listen - Stock Traders Daily

Dec 08, 2024

Dec 06, 2024

Polar Asset Management Partners Inc. Purchases New Position in Delcath Systems, Inc. (NASDAQ:DCTH) - MarketBeat

Dec 06, 2024

Dec 03, 2024

Delcath to trial Hepzato drug device combo in colorectal cancer - Yahoo Finance

Dec 03, 2024

Dec 02, 2024

FDA finishes review of Delcath’s IND application of HEPZATO combo trial - TipRanks

Dec 02, 2024

Delcath Secures FDA Clearance for Phase 2 Trial of HEPZATO in Colorectal Cancer - StockTitan

Dec 02, 2024

Delcath Systems (NASDAQ:DCTH) jumps 13% this week, taking one-year gains to 330% - Yahoo Finance

Dec 02, 2024

Nov 29, 2024